Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
Authors:
Guttorm Raknes; Lars Småbrekke
Published in the journal:
PLoS ONE 14(10)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0223545
There are a number of errors in Table 3. The value in column 7 "% points" for the line “LDN x 4+” in the group “All examined medicines” should be -3.3, not 0. Additionally, the p-values in the ninth column “P” are incorrect. Please see the correct Table 3 here.
There are a number of errors in S2 Table. The p-values in the ninth column “P” are incorrect. Please view the correct S2 Table below.
Supporting information
S2 Table [pdf]
The number of users of medicines classified as Other DMARDs among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.
Zdroje
1. Raknes G, Småbrekke L (2019) Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study. PLoS ONE 14(2): e0212460. https://doi.org/10.1371/journal.pone.0212460 30763385
Článok vyšiel v časopise
PLOS One
2019 Číslo 10
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Ne každé mimoděložní těhotenství musí končit salpingektomií
- Flibanserin není ženská Viagra
Najčítanejšie v tomto čísle
- Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study
- Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
- Prevalence of pectus excavatum (PE), pectus carinatum (PC), tracheal hypoplasia, thoracic spine deformities and lateral heart displacement in thoracic radiographs of screw-tailed brachycephalic dogs
- Experimentally validated simulation of coronary stents considering different dogboning ratios and asymmetric stent positioning